Fatal pull: MRI machine claims life of man wearing metal necklace in New York
The fatal incident occurred on Wednesday at Nassau Open MRI and is under investigation.
According to a statement by the Nassau County Police Department cited by The New York Times, the man entered the MRI room at 4.34pm local time wearing a 'large metallic chain' around his neck. He did not have authorisation to be in the room, police said.
The magnetic force of the machine pulled the man toward it, triggering what authorities described as a 'medical episode'. He was transported to a nearby hospital but died the following afternoon at 2.36pm.
Police have not released the man's name. A spokesman said yesterday that the investigation is ongoing and that no additional information was currently available.
Nassau Open MRI did not respond to requests for comment.
Magnetic resonance imaging (MRI) machines use powerful magnets and radio waves to generate detailed images of internal organs and tissues.
The machines' strong magnetic fields can be dangerous if metallic objects are brought into the room, with the National Institute of Biomedical Imaging and Bioengineering noting that items as large as wheelchairs can become projectiles.
Patients and staff are typically required to remove all metal objects before entering an MRI room. People with certain medical implants may be advised against undergoing scans.
Serious incidents involving MRI machines are rare but have occurred before.
In 2001, a six-year-old boy in New York was killed when a metal oxygen tank was pulled into the machine during a scan.
In 2018, a man in India carrying an oxygen tank died after entering an MRI room.
Most recently in 2023, a nurse in California was crushed and injured when an MRI machine's magnetic pull dragged a hospital bed into her.
Nassau Open MRI offers both closed and open MRI scans, with the latter designed to be more accessible for patients who experience claustrophobia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
12 hours ago
- Malay Mail
Samsung Galaxy Watch 8 hands-on: Smarter sleep, antioxidant tracking and mental wellness
Shortly after Samsung's Galaxy Unpacked event in New York, I had the chance to participate in a dedicated Health Immersion session to experience the Galaxy Watch 8 series' new and refined health features. Besides having a slimmer squircle design and a brighter display with up to 3000 nits, the Samsung Galaxy Watch 8 series is designed to encourage sustainable and positive changes covering sleep, stress, fitness and even nutrition. Smarter sleep insights, not just sleep hours Samsung has been refining its sleep tracking feature over several generations of its wearables. Besides logging how many hours you've sleep, the Galaxy Watch 8 not only detects sleep stages (light, deep, REM) but it also measures your blood oxygen level, heart rate and respiratory patterns to provide a more complete Sleep Score. There's also an updated Sleep Coaching function which guides users to develop good habits to help you to relax before you go to bed. The updated Sleep Coaching feature helps users build healthy habits to relax before bedtime. — SoyaCincau pic At the session, Dr Vanessa Hill, a sleep scientist and a creator behind the BrainCraft YouTube channel, shared how quality of sleep isn't just about total hours, but also about consistency. She also highlighted that the Galaxy Watch 8 and Samsung Health app now offer Bedtime Guidance, which suggests optimal bedtime based on your lifestyle and sleep history. It also nudges you with reminders to help you stick to it. Dr Hill cited findings from the UK Biobank study covering nearly 61,000 participants, noting that sleep regularity was a stronger predictor of all-cause mortality than sleep duration. She also shared the concept of bedtime procrastination as a meaningful and modifiable contributor to inadequate sleep associated with shorter sleep duration, poorer sleep quality and increased daytime fatigue. Accountability, she said, is a missing yet desired factor. Many people struggle to maintain a consistent bedtime without external expectations or someone to hold them accountable. And night time, she emphasised, is the hardest time to motivate to sleep as self-discipline is at its lowest compared to other times of the day. The Galaxy Watch 8 also features a Sleep Apnea Detection feature, which received De Novo authorisation from the US FDA, to detect moderate to severe signs of Sleep Apnea over a two-night monitoring period. There's also a Vascular Load feature that helps to monitor your stress levels on your vascular system while you sleep. On the plus side, wearing the Galaxy Watch 8 overnight is now more comfortable thanks to its lighter and slimmer build, and redesigned dynamic lug system. However, it is still recommended to perform a quick battery top up before you start the day as I wouldn't count on the Galaxy Watch 8 to last for two straight days on a single charge. A new health metric: Antioxidant Index One key highlight from the session was the new Antioxidant Index feature. The Samsung Galaxy Watch 8 is the first smartwatch to measure the Antioxidant Index and it takes just 5 seconds. Users simply place their thumb on the BioActive Sensor behind the watch to get a quick reading. It measures carotenoid levels in the skin which are essentially pigments found in red, yellow and orange fruits and vegetables like tomatoes, carrots, and oranges. Carotenoids are antioxidants that the body cannot produce on its own and must be obtained through food or dietary supplements. Alongside carotenoids, fruits and vegetables are rich in other antioxidants such as Vitamin C, Vitamin E, polyphenols, and retinol. Antioxidants are important to maintain good health as it can help to prevent chronic illnesses by neutralising free radicals and reducing oxidative stress in the body. The Antioxidant Index ranges from 0 to 100, and is meant to help users determine whether they're eating enough fruit and vegetables. From my own test, my Antioxidant Index levels are very low as the Galaxy Watch 8 constantly recorded less than 40 points. According to the World Health Organisation (WHO), the recommended intake is at least 400g of fruits and vegetables per day. The Antioxidant Index is an interesting new feature to encourage healthy aging with the right daily intake of fruits and vegetables. It complements existing metrics like body fat percentage and skeletal muscle mass in the Samsung Health. Mindfulness to keep your stress levels in check Samsung continues to expand on its mindfulness toolkit with features that promote emotional awareness and relaxation. In the session, we tried a short breathing and reflection activity with the Galaxy Watch 8. These mindfulness features including Mood Check-in and guided breathing exercises have been around on previous Galaxy Watch models. The breathing modes include Box (4-4-4-4) for relaxation, Long Exhale (4-7-8) for sleep, and Equal breathing (5-0-5) for better focus. Alternatively, or users can configure their own custom routines to suit different moments throughout the day. If the Watch detects a high level of stress, a High Stress Alert will alert you and recommends taking a break and to manage your stress levels in real time. The built-in Mindfulness Tracker on your wrist lets you check-in your current mood and recommends breathing exercise to reduce your stress levels. Personal Running Coach on your wrist Whether you're practicing for an upcoming run or simply just want to move more, the Galaxy Watch 8 features a running coach that acts like your personal trainer. To find out your running level on a scale from 1 to 10, it can measure your current fitness with a 12-minute run and creates a tailored 3-5- week training plan just for you. It delivers real-time guidance, motivational insights, and continuous progress updates, to help you achieve your running goals. This segment of the Health Immersion session was led by John Peel, a personal trainer and former NCAA Division football player. Some of his shared tips include: Focus more on time over distance—especially for beginners. Consistency matters more than speed. Maintain a relaxed posture: loose jaw, loose shoulders, and relaxed fingertips. Be mindful of your gear: running shoes typically last 300–500 miles (about 480–800 km). A new pair can reset your mindset and act as a motivational boost. Track your journey with Samsung Health and hold yourself accountable. From the Health Immersion session, Samsung is trying to position the Galaxy Watch 8 not just as a fitness device paired to your smartphone but also a holistic health companion. Across the different features from sleep tracking to antioxidant index and mindfulness tools, there's a clear focus on helping users better understand their daily habits beyond just counting steps. Galaxy Watch 8 includes a built-in running coach to support your training and daily fitness goals. — SoyaCincau pic At the moment, the Samsung Galaxy Watch 8 series are available for pre-order and here's a recap on the pricing: Galaxy Watch 8 (40mm) WiFi – RM1,299 Galaxy Watch 8 (40mm) WiFi + LTE – RM1,599 Galaxy Watch 8 (44mm) WiFi – RM1,399 Galaxy Watch 8 (44mm) WiFi + LTE – RM1,699 Galaxy Watch 8 Classic (46mm) WiFi – RM1,799 Galaxy Watch 8 Classic (46mm) WiFi + LTE – RM2,099 Galaxy Watch Ultra 2025 (47mm) WiFi + LTE – RM3,399 As part of the pre-order promo, Samsung Malaysia is offering savings worth up to RM966. You can order online via Samsung's Online Store, Shopee and Lazada. — SoyaCincau
The Star
2 days ago
- The Star
Plastic in our veins
Microplastics are broadly defined as plastic particles less than 5mm in size. Even smaller are nanoplastics, measuring under one micrometre. — Tim Lenzen/The New York Times RECENT headlines have reignited concerns over microplastics – tiny fragments of plastic – and the damage they may be inflicting on our health. From the peaks of Mount Everest to the depths of the Mariana Trench, these microscopic particles have infiltrated every corner of our environment. And now, they've made their way into us. Cancel anytime. Ad-free. Full access to Web and App. RM 13.90/month RM 9.73 /month Billed as RM 9.73 for the 1st month, RM 13.90 thereafter. RM 12.39/month RM 8.63 /month Billed as RM 103.60 for the 1st year, RM 148 thereafter.
Malay Mail
2 days ago
- Malay Mail
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited( - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA!In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited( took the lead in building the "NewCo+RWA" Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin "IVDDollar" (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion July 18, 2025, local time, US President Trump signed the "Guidance and Establishment of the United States Stablecoin National Innovation Act" (hereinafter referred to as the "Genius Act") at the White House, establishing the legal status of stablecoins as "digital dollars". The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the "Hong Kong + US" dual hub compliance architecture strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the "Genius Act" for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong "Stablecoin Ordinance" to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the "Hong Kong Stock Stablecoin Concept Sector".The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology:1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets;2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's "1:1 redeemable" requirements;3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of "digital assets + traditional equity" to attract two-way inflows of traditional medical capital and crypto-native implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional Group's strategic advancement has always followed the three-dimensional path of "regulatory compliance-technological innovation-ecological synergy". In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of "NewCo+RWA+stablecoin".Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and #IVDMedicalHoldingLimited The issuer is solely responsible for the content of this announcement.
